Catalent to Buy Supplement Maker Bettera Holdings for $1 Billion

The contract drug manufacturer’s deal for closely held Bettera would expand Catalent’s manufacturing capabilities for vitamin, minerals and supplements to make them in gummy form.

Gores Guggenheim SPAC Nears Deal to Combine With Polestar

Polestar is nearing a deal to go public through a merger...

U.S.-EU Trade Summit in Pittsburgh Aims to Deepen Trans-Atlantic Ties

Senior European Union officials including Margrethe Vestager will meet with U.S....

China Has New Way to Fight IP Theft Claims

Chinese technology giants have seized on a new legal tactic to...

Economy Week Ahead: Consumer Spending, Inflation, Manufacturing

Markets this week will be focusing on U.S. consumer spending and...